Endoglin (ENG, HHT1) and activin receptor-like kinase 1 (ALK1, HHT2) are major causative genes for HHT, with at least 90% of HHT patients having a mutation in one of these genes [5]. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.